The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...
By Nikhil Sharma (Reuters) -European shares reached a record high on Friday, led by technology and healthcare stocks, as ...
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...
Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen. Read ...
Reports Q4 revenue $13.2B vs. $11.4B last year. Vas Narasimhan, CEO of Novartis (NVS), said: “In our first full year as a pure-play innovative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback